Skip to main content
. Author manuscript; available in PMC: 2016 Feb 17.
Published in final edited form as: Lancet Respir Med. 2015 Mar 24;3(6):451–461. doi: 10.1016/S2213-2600(15)00095-8

Table 3.

Meta-analysis findings for estimated Xpert and microscopy sensitivity and specificity against the reference standards

Number of studies (number of children) Pooled and predicted median sensitivity (pooled 95% credible interval; predicted 95% credible interval) Pooled and predicted median specificity (pooled 95% credible interval; predicted 95% credible interval)
Xpert against culture
Expectorated and induced sputum 12 (2380)12,1416,1820,22,23,25* 62% (51–73; 30–87) 98% (97–99; 90–100)
Gastric lavage 7 (1319)1214,17,20,21 66% (51–81; 33–91) 98% (96–99; 91–100)
Xpert against culture-negative and started on ATT
Expectorated and induced sputum 8 (1512)1416,18,19,23,25* 2% (1–3; 0–6) 100% (99–100; 99–100)
Smear microscopy against culture
Expectorated and induced sputum 12 (2380)12,1416,1820,22,23,25* 26% (14–39; 4–69) 100% (99–100; 94–100)
Gastric lavage 7 (1319)1214,17,20,21 22% (12–35; 6–51) 99% (97–100; 93–100)

Includes published and one unpublished study. ATT=antituberculosis treatment.

*

Expectorated and induced sputum cohorts from reference 16 included as separate studies.

Also includes data from Walters E, Desmond Tutu TB Centre, personal communication.